Handling should be performed only by trained personnel using appropriate PPE, labeling, and documentation controls
This suggests that the dimer form has a significantly higher potency in inhibiting GSTP1 compared to the monomer
Per the FDA document: it had intended to withdraw only the injectable route nomination, not the non-injectable
CagrilintideSemaglutide (CagriSema): Phase 3 REDEFINE 1 Summary Garvey WT, Blher M, Osorto Contreras CK, Davies MJ, Winning Lehmann E, Pietilinen KH, Rubino D, Sbraccia P, Wadden T, Zeuthen N, Wilding JPH
Maintain cold chain compliance logs
Fluid Composition: Some people are sensitive to specific electrolytes or ingredients in IV solutions, such as sodium chloride or potassium